Status:
COMPLETED
Effect of Tertiary A-level Hospital Remote Intervention on MACCE, Adherence to Drugs and Risk Factors Control in Patients With Stable Coronary Artery Disease Compared With Traditional Community Hospital Follow-up
Lead Sponsor:
Chinese Academy of Medical Sciences, Fuwai Hospital
Conditions:
Stable Chronic Angina
Ischemic Heart Disease
Eligibility:
All Genders
18-99 years
Brief Summary
The study was a multicenter, two-arm, parallel, open label, prospective study intended for to compare effect of offline community hospital intervention on adherence to drugs and risk factors control i...
Detailed Description
Objective: This study is intended for to compare effect of offline community hospital intervention on adherence to drugs and risk factors control in patients with stable coronary artery disease compar...
Eligibility Criteria
Inclusion
- aged between 18-99 years
- diagnosed with SCAD according to guidelines by coronary CTA or coronary angiography (including stable angina, ischemic cardiomyopathy, and the stable course after acute coronary syndrome)
- have sufficient Chinese language proficiency to reading, speaking and listening
- live with at least one caregiver or guardian in the household
- presence of stable hemodynamics without using vasopressor
- able to individually consent
- not participating in any other clinical trial
Exclusion
- unable to provide informed consent
- unable to be involved in clinical follow up and treatment
- suffered comorbidity with a life expectancy of less than 1 year
- have contra-indication to cardiac rehabilitation
- acute coronary syndrome
Key Trial Info
Start Date :
September 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
1424 Patients enrolled
Trial Details
Trial ID
NCT04795505
Start Date
September 1 2018
End Date
January 1 2023
Last Update
February 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai Hospital, Chinese Academy of Medical Science; National Center for Cardiovascular Diseases
Beijing, Beijing Municipality, China, 100000